Atlas Trials

VX-950-TiDP24-C132: A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Telaprevir.

Clinical trial NCT00903773 · COMPLETED

Trial details

NCT number
NCT00903773
Sponsor
Tibotec BVBA
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis CKidney Diseases
Start date
2009-06-01
Primary completion
2010-02-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.